Suppr超能文献

长期的收缩活动和甲状腺激素补充可产生具有成人样结构和功能的工程化大鼠心肌。

Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function.

机构信息

Department of Biomedical Engineering, Duke University, NC 27708, United States.

Department of Biomedical Engineering, Duke University, NC 27708, United States.

出版信息

Acta Biomater. 2018 Sep 15;78:98-110. doi: 10.1016/j.actbio.2018.08.003. Epub 2018 Aug 4.

Abstract

UNLABELLED

The field of cardiac tissue engineering has developed rapidly, but structural and functional immaturity of engineered heart tissues hinder their widespread use. Here, we show that a combination of low-rate (0.2 Hz) contractile activity and thyroid hormone (T3) supplementation significantly promote structural and functional maturation of engineered rat cardiac tissues ("cardiobundles"). The progressive maturation of cardiobundles during first 2 weeks of culture resulted in cell cycle exit and loss of spontaneous activity, which in longer culture yielded decreased contractile function. Maintaining a low level of contractile activity by 0.2 Hz pacing between culture weeks 3 and 5, combined with T3 treatment, yielded significant growth of cardiobundle and myocyte cross-sectional areas (by 68% and 32%, respectively), increased nuclei numbers (by 22%), improved twitch force (by 39%), shortened action potential duration (by 32%), polarized N-cadherin distribution, and switch from immature (slow skeletal) to mature (fast) cardiac troponin I isoform expression. Along with advanced functional output (conduction velocity 53.7 ± 0.8 cm/s, specific force 70.1 ± 5.8 mN/mm), quantitative ultrastructural analyses revealed similar metrics and abundance of sarcomeres, T-tubules, M-bands, and intercalated disks compared to native age-matched (5-week) and adult (3-month) ventricular myocytes. Unlike 0.2 Hz regime, chronic 1 Hz pacing resulted in significant cardiomyocyte loss and formation of necrotic core despite the use of dynamic culture. Overall, our results demonstrate remarkable ultrastructural and functional maturation of neonatal rat cardiomyocytes in 3D culture and reveal importance of combined biophysical and hormonal inputs for in vitro engineering of adult-like myocardium.

STATEMENT OF SIGNIFICANCE

Compared to human stem cell-derived cardiomyocytes, neonatal rat ventricular myocytes show advanced maturation state which makes them suitable for in vitro studies of postnatal cardiac development. Still, maturation process from a neonatal to an adult cardiomyocyte has not been recapitulated in rodent cell cultures. Here, we show that low-frequency pacing and thyroid hormone supplementation of 3D engineered neonatal rat cardiac tissues synergistically yield significant increase in cell and tissue volume, robust formation of T-tubules and M-lines, improved sarcomere organization, and faster and more forceful contractions. To the best of our knowledge, 5-week old engineered cardiac tissues described in this study are the first that exhibit both ultrastructural and functional characteristics approaching or matching those of adult ventricular myocardium.

摘要

未加说明

心脏组织工程领域发展迅速,但工程化心脏组织的结构和功能不成熟限制了其广泛应用。在这里,我们发现低频率(0.2Hz)收缩活性和甲状腺激素(T3)补充的组合可显著促进工程化大鼠心脏组织(“心Bundle”)的结构和功能成熟。在培养的前 2 周内,心 Bundle 的逐渐成熟导致细胞周期退出和自发性活动丧失,而在较长的培养中则导致收缩功能降低。在第 3 至 5 周的培养期间通过 0.2Hz 起搏维持低水平的收缩活性,并结合 T3 处理,可使心 Bundle 和心肌细胞的横截面积显著增加(分别增加 68%和 32%),核数量增加(增加 22%),收缩力提高(增加 39%),动作电位时程缩短(缩短 32%),N-钙黏蛋白分布极化,并从不成熟(慢骨骼肌)转变为成熟(快)肌钙蛋白 I 同工型表达。随着功能输出的提高(传导速度为 53.7±0.8cm/s,比力为 70.1±5.8mN/mm),定量超微结构分析显示与同龄(5 周)和成年(3 个月)心室肌细胞相比,有相似的肌节、T 管、M 带和闰盘的指标和丰度。与 0.2Hz 方案不同,尽管使用了动态培养,但 1Hz 的慢性起搏仍导致心肌细胞大量损失和坏死核心的形成。总体而言,我们的结果表明,在 3D 培养中,新生大鼠心肌细胞具有显著的超微结构和功能成熟,并且证明了生物物理和激素输入的综合作用对于体外构建成人样心肌的重要性。

相似文献

2
Dynamic culture yields engineered myocardium with near-adult functional output.
Biomaterials. 2016 Dec;111:66-79. doi: 10.1016/j.biomaterials.2016.09.024. Epub 2016 Sep 30.
3
Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.
J Mol Cell Cardiol. 2014 Sep;74:151-61. doi: 10.1016/j.yjmcc.2014.05.009. Epub 2014 May 19.
4
Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes.
Exp Biol Med (Maywood). 2017 Nov;242(17):1643-1656. doi: 10.1177/1535370217701006. Epub 2017 Mar 26.
5
Age-dependent functional crosstalk between cardiac fibroblasts and cardiomyocytes in a 3D engineered cardiac tissue.
Acta Biomater. 2017 Jun;55:120-130. doi: 10.1016/j.actbio.2017.04.027. Epub 2017 Apr 25.
6
Effect of thyroid hormone on the contractility of self-organized heart muscle.
In Vitro Cell Dev Biol Anim. 2008 Jul-Aug;44(7):204-13. doi: 10.1007/s11626-008-9094-0. Epub 2008 Jun 5.
7
Tissue engineering of a differentiated cardiac muscle construct.
Circ Res. 2002 Feb 8;90(2):223-30. doi: 10.1161/hh0202.103644.
9
Controlling the structural and functional anisotropy of engineered cardiac tissues.
Biofabrication. 2014 Jun;6(2):024109-24109. doi: 10.1088/1758-5082/6/2/024109. Epub 2014 Apr 10.
10
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes.
Biomaterials. 2013 Jul;34(23):5813-20. doi: 10.1016/j.biomaterials.2013.04.026. Epub 2013 May 2.

引用本文的文献

1
Short-Term Electrical Stimulation Impacts Cardiac Cell Structure and Function.
J Tissue Eng Regen Med. 2025 Jun 6;2025:3748093. doi: 10.1155/term/3748093. eCollection 2025.
2
3
In vitro vascularization improves in vivo functionality of human engineered cardiac tissues.
Acta Biomater. 2024 Nov 10. doi: 10.1016/j.actbio.2024.11.014.
4
Engineered Cardiac Tissues as a Platform for CRISPR-Based Mitogen Discovery.
Adv Healthc Mater. 2025 Jan;14(1):e2402201. doi: 10.1002/adhm.202402201. Epub 2024 Nov 7.
5
Nanoscale organization of cardiac calcium channels is dependent on thyroid hormone status.
Am J Physiol Heart Circ Physiol. 2024 Nov 1;327(5):H1309-H1326. doi: 10.1152/ajpheart.00272.2024. Epub 2024 Oct 4.
6
Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium.
Sci Adv. 2024 Jan 26;10(4):eadh2598. doi: 10.1126/sciadv.adh2598. Epub 2024 Jan 24.
7
FRESH™ 3D bioprinted cardiac tissue, a bioengineered platform for pharmacology.
APL Bioeng. 2023 Dec 1;7(4):046113. doi: 10.1063/5.0163363. eCollection 2023 Dec.
8
Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy.
Clin Cardiol. 2023 Dec;46(12):1569-1577. doi: 10.1002/clc.24156. Epub 2023 Sep 15.

本文引用的文献

1
Advanced maturation of human cardiac tissue grown from pluripotent stem cells.
Nature. 2018 Apr;556(7700):239-243. doi: 10.1038/s41586-018-0016-3. Epub 2018 Apr 4.
2
Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation.
Biomaterials. 2018 Mar;159:48-58. doi: 10.1016/j.biomaterials.2018.01.002. Epub 2018 Jan 3.
5
Genetically Encoded Photoactuators and Photosensors for Characterization and Manipulation of Pluripotent Stem Cells.
Theranostics. 2017 Aug 18;7(14):3539-3558. doi: 10.7150/thno.20593. eCollection 2017.
6
Age-dependent functional crosstalk between cardiac fibroblasts and cardiomyocytes in a 3D engineered cardiac tissue.
Acta Biomater. 2017 Jun;55:120-130. doi: 10.1016/j.actbio.2017.04.027. Epub 2017 Apr 25.
7
Engineering Cardiac Muscle Tissue: A Maturating Field of Research.
Circ Res. 2017 Apr 28;120(9):1487-1500. doi: 10.1161/CIRCRESAHA.117.310738.
8
Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
Circulation. 2017 May 9;135(19):1832-1847. doi: 10.1161/CIRCULATIONAHA.116.024145. Epub 2017 Feb 6.
9
Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells.
Sci Transl Med. 2016 Nov 2;8(363):363ra148. doi: 10.1126/scitranslmed.aaf8781.
10
Dynamic culture yields engineered myocardium with near-adult functional output.
Biomaterials. 2016 Dec;111:66-79. doi: 10.1016/j.biomaterials.2016.09.024. Epub 2016 Sep 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验